Welcome to LookChem.com Sign In|Join Free

Shanghai Upbio Tech Co.,Ltd

Assessed Supplier Enterprise Certification

Assessed
Supplier
11th
years
Home>>Products>>high quality INCB024360

Product Certification&
Enterprise Certification

More Detail

Shanghai Upbio Tech Co.,Ltd

Country: China (Mainland)

Business Type:Lab/Research institutions

Ms.Emma Hu

Tel: +86-21-52196435

Mobile:

Tel: +86-21-52196435

Fax: +86-21-54386655

URL: http://www.up-bio.com

Province/state: Shanghai

City: Shanghai

Street: No.2 Floor,No.979 Yunhan Rd,Nicheng,Pudong New Area,Shanghai,China

MaxCard:


qq
    x
  • Ms.Nancy
Contact Suppliers

high quality INCB024360

CAS NO.914471-09-3

  • FOB Price: USD: 9.00-9.00 /Gram Get Latest Price
  • Min.Order: 1 Gram
  • Payment Terms: T/T,
  • Available Specifications:

    99%(1-100)Gram

Contact Supplier

Product Details

Keywords

  • INCB024360
  • 914471-09-3
  • Pharmaceutical Chemicals

Quick Details

  • ProName: high quality INCB024360
  • CasNo: 914471-09-3
  • Appearance: White powder
  • Application: lab research
  • DeliveryTime: 3days
  • PackAge: 10g/pack,100g/pack,1kg/pack
  • Port: Shanghai port
  • ProductionCapacity: 10000 Kilogram/Year
  • Purity: 99%min
  • Storage: storage in a dry, ventilated place und...
  • Transportation: BY EMS,FEDEX,AIR
  • LimitNum: 1 Gram
  • Valid Period: 2years
  • Batch: 20140302

Superiority

 

1,In No Less five years exporting experience.

2.Lower Price with higher quality

3,Free sample

4,We are sincerely responsible for the "product quality" and "After Service"

Details

INCB024360 is an orally available hydroxyamidine and inhibitor of indoleamine 2,3-dioxygenase (IDO1), with potential immunomodulating and antineoplastic activities. INCB024360 targets and binds to IDO1, an enzyme responsible for the oxidation of tryptophan into kynurenine. By inhibiting IDO1 and decreasing kynurenine in tumor cells, INCB024360 increases and restores the proliferation and activation of various immune cells, including dendritic cells (DCs), NK cells, and T-lymphocytes, as well as interferon (IFN) production, and a reduction in tumor-associated regulatory T cells (Tregs). Activation of the immune system, which is suppressed in many cancers, may inhibit the growth of IDO1-expressing tumor cells. IDO1 is overexpressed by a variety of tumor cell types and DCs

 

only for lab resarch